CLINICAL_TRIALS
trial_result
· 2022-09-13
Clinical Trial Update: Magnesium Treating Subarachnoid Hemorrhage Vasospasm [Phase 2, Phase 3]
Summary
A clinical trial investigating magnesium for treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage, spanning Phase 2 and Phase 3, with unknown cu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt | Conditions: Subarachnoid Hemorrhage, Aneurysmal, Cerebral Vasospasm | Phase 2, Phase 3 | Status: UNKNOWN